These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30566194)
1. Immunotherapy 2.0: Improving the Response to Checkpoint Inhibitors. Friedrich MJ JAMA; 2019 Jan; 321(2):131-133. PubMed ID: 30566194 [No Abstract] [Full Text] [Related]
2. Immune Checkpoint Inhibitors for Urologic Cancer: The Tip of the Iceberg? Powles T Eur Urol; 2015 Aug; 68(2):280-2. PubMed ID: 25800945 [No Abstract] [Full Text] [Related]
3. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G. Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720 [TBL] [Abstract][Full Text] [Related]
4. Reversing T-cell Dysfunction and Exhaustion in Cancer. Zarour HM Clin Cancer Res; 2016 Apr; 22(8):1856-64. PubMed ID: 27084739 [TBL] [Abstract][Full Text] [Related]
5. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection. Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197 [TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. Hargadon KM; Johnson CE; Williams CJ Int Immunopharmacol; 2018 Sep; 62():29-39. PubMed ID: 29990692 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer. Hashemi-Sadraei N; Sikora AG; Brizel DM Am Soc Clin Oncol Educ Book; 2016; 35():e277-82. PubMed ID: 27249733 [TBL] [Abstract][Full Text] [Related]
8. Releasing the Brakes on Cancer Immunotherapy. Ribas A N Engl J Med; 2015 Oct; 373(16):1490-2. PubMed ID: 26348216 [No Abstract] [Full Text] [Related]
9. T-cell cross-reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors. Sioud M Scand J Immunol; 2018 Mar; 87(3):. PubMed ID: 29381830 [TBL] [Abstract][Full Text] [Related]
10. The use of immunotherapy in the treatment of melanoma. Achkar T; Tarhini AA J Hematol Oncol; 2017 Apr; 10(1):88. PubMed ID: 28434398 [TBL] [Abstract][Full Text] [Related]
11. [Advances in immune checkpoint inhibitors in gastrointestinal cancer]. Zhu XR; Zheng LZ Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):646-649. PubMed ID: 28926891 [TBL] [Abstract][Full Text] [Related]
12. A novel approach to candidemia? The potential role of checkpoint inhibition. Mellinghoff SC; von Bergwelt-Baildon M; Schößer HA; Cornely OA Med Mycol; 2019 Feb; 57(2):151-154. PubMed ID: 30462325 [TBL] [Abstract][Full Text] [Related]
13. The future of immune checkpoint cancer therapy after PD-1 and CTLA-4. Hahn AW; Gill DM; Pal SK; Agarwal N Immunotherapy; 2017 Jun; 9(8):681-692. PubMed ID: 28653573 [TBL] [Abstract][Full Text] [Related]
14. Checkpoint inhibitors in bladder and renal cancers: results and perspectives. Aoun F; Kourie HR; Sideris S; Roumeguère T; van Velthoven R; Gil T Immunotherapy; 2015; 7(12):1259-71. PubMed ID: 26595284 [TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint inhibitors for cancer treatment. Park J; Kwon M; Shin EC Arch Pharm Res; 2016 Nov; 39(11):1577-1587. PubMed ID: 27770382 [TBL] [Abstract][Full Text] [Related]
16. Checkpoint Inhibitors: Conquering Cancer with a Little (T)-Help from Our Microbial Friends. Asmar N; Ibrahim T; Rey JF Dig Dis Sci; 2018 Sep; 63(9):2177-2179. PubMed ID: 29982987 [No Abstract] [Full Text] [Related]
17. Checkpoint Blockade for the Treatment of Advanced Melanoma. Callahan MK; Flaherty CR; Postow MA Cancer Treat Res; 2016; 167():231-50. PubMed ID: 26601865 [TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy. Durgeau A; Virk Y; Corgnac S; Mami-Chouaib F Front Immunol; 2018; 9():14. PubMed ID: 29403496 [TBL] [Abstract][Full Text] [Related]
19. The Era of Immune Checkpoint Therapy: From Cancer to Viral Infection-A Mini Comment on the 2018 Medicine Nobel Prize. Liu J; Pan W; Yang D Virol Sin; 2018 Dec; 33(6):467-471. PubMed ID: 30570713 [No Abstract] [Full Text] [Related]